Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free
free
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll An update on pharmacologic approaches to bronchopulmonary dysplasia Ghanta S; Leeman KT; Christou HSemin Perinatol 2013[Apr]; 37 (2): 115-23Bronchopulmonary dysplasia (BPD) is the most prevalent long-term morbidity in surviving extremely preterm infants and is linked to increased risk of reactive airways disease, pulmonary hypertension, post-neonatal mortality, and adverse neurodevelopmental outcomes. BPD affects approximately 20% of premature newborns, and up to 60% of premature infants born before completing 26 weeks of gestation. It is characterized by the need for assisted ventilation and/or supplemental oxygen at 36 weeks postmenstrual age. Approaches to prevention and treatment of BPD have evolved with improved understanding of its pathogenesis. This review will focus on recent advancements and detail current research in pharmacotherapy for BPD. The evidence for both current and potential future experimental therapies will be reviewed in detail. As our understanding of the complex and multifactorial pathophysiology of BPD changes, research into these current and future approaches must continue to evolve.|Adrenal Cortex Hormones/therapeutic use[MESH]|Bronchodilator Agents/therapeutic use[MESH]|Bronchopulmonary Dysplasia/*drug therapy/prevention & control[MESH]|Diuretics/therapeutic use[MESH]|Humans[MESH]|Infant, Low Birth Weight[MESH]|Infant, Newborn[MESH]|Infant, Premature[MESH]|Infant, Very Low Birth Weight[MESH]|Pulmonary Surfactants/therapeutic use[MESH]|Vitamin A/therapeutic use[MESH]|Vitamins/therapeutic use[MESH]|Xanthines/therapeutic use[MESH] |